tm logo
ONGOZIG
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 20 May 2024

Last Applicant/ Owned by

86 Morris Avenue

Summit

NJ

07901

Serial Number

88877227 filed on 17th Apr 2020

Registration Number

N/A

Correspondent Address

Marilyn F. Kelly

Marilyn F. Kelly BRISTOL-MYERS SQUIBB COMPANY

TRADEMARKS DEPT., MAILSTOP D4243

PRINCETON, NJ 08648-4000

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ONGOZIG

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprol Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 88877227

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 00138786-US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
20th May 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
20th May 2024ABANDONMENT - NO USE STATEMENT FILED
14th Oct 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13th Oct 2023SOU EXTENSION 5 GRANTED
13th Oct 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
03rd Oct 2023SOU EXTENSION 5 FILED
03rd Oct 2023SOU TEAS EXTENSION RECEIVED
31st Mar 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29th Mar 2023SOU EXTENSION 4 GRANTED
29th Mar 2023SOU EXTENSION 4 FILED